Bioconjugated gold nanoparticles as a molecular based contrast agent: Implications for imaging of deep tumors using optoacoustic tomography

John A. Copland, Mohammad Eghtedari, Vsevolod Popov, Nicholas Kotov, Natasha Mamedova, Massoud Motamedi, Alexander A. Oraevsky

Research output: Contribution to journalArticle

268 Citations (Scopus)

Abstract

Purpose: Optoacoustic tomography (OAT) is a novel medical imaging method that uses optical illumination and ultrasonic detection to produce deep tissue images based on their light absorption. Abnormal angiogenesis in advanced tumors, that increases the blood content of the tumor, is an endogenous contrast agent for OAT. In early stages, however, angiogenesis is not sufficient to differentiate a tumor from normal tissue; justifying the application of an exogenous contrast agent. We have developed a molecular based contrast agent composed of gold nanoparticles conjugated to a monoclonal antibody that improves OAT imaging to potentiate its use in imaging deep tumors in early stages of cancer or metastatic lesions. Procedure: Due to their strong optoacoustic signal, we used gold nanoparticles (NPs) as a contrast agent. To target NPs to breast cancer cells, we conjugated NPs to a monoclonal antibody that specifically binds cell surface receptors known to be overexpressed in human breast tumors. Results: In a series of in vitro experiments, Herceptin® (monoclonal antibody that binds HER2/neu) conjugated to 40nm NPs (Mab/NPs) selectively targeted human SK-BR-3 breast cancer cells. The breast cancer cells were detected and imaged by OAT in a gelatin phantom that optically resembled breast tissue. Sensitivity experiments showed that a concentration as low as 10 9 NPs per ml were detectable at a depth of 6 cm. Conclusion: Experimental data together with theoretical analysis demonstrate the feasibility of detection of deeply seeded small tumors that express tumor associated antigens using targeted gold NPs and OAT.

Original languageEnglish (US)
Pages (from-to)341-349
Number of pages9
JournalMolecular Imaging and Biology
Volume6
Issue number5
DOIs
StatePublished - Sep 2004

Fingerprint

Gold
Nanoparticles
Contrast Media
Tomography
Neoplasms
Monoclonal Antibodies
Breast Neoplasms
Cell Surface Receptors
Neoplasm Antigens
Diagnostic Imaging
Gelatin
Lighting
Ultrasonics
Breast

Keywords

  • Cancer
  • Detection
  • Diagnostics
  • Gold nanoparticles
  • Herceptin
  • Imaging
  • Laser optoacoustic imaging system
  • Molecular probes
  • Nanotechnology
  • Optoacoustics
  • Targeting

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Radiology Nuclear Medicine and imaging

Cite this

Bioconjugated gold nanoparticles as a molecular based contrast agent : Implications for imaging of deep tumors using optoacoustic tomography. / Copland, John A.; Eghtedari, Mohammad; Popov, Vsevolod; Kotov, Nicholas; Mamedova, Natasha; Motamedi, Massoud; Oraevsky, Alexander A.

In: Molecular Imaging and Biology, Vol. 6, No. 5, 09.2004, p. 341-349.

Research output: Contribution to journalArticle

Copland, John A. ; Eghtedari, Mohammad ; Popov, Vsevolod ; Kotov, Nicholas ; Mamedova, Natasha ; Motamedi, Massoud ; Oraevsky, Alexander A. / Bioconjugated gold nanoparticles as a molecular based contrast agent : Implications for imaging of deep tumors using optoacoustic tomography. In: Molecular Imaging and Biology. 2004 ; Vol. 6, No. 5. pp. 341-349.
@article{d5369b4f1c964e3e883a6dd0e2e5d6f2,
title = "Bioconjugated gold nanoparticles as a molecular based contrast agent: Implications for imaging of deep tumors using optoacoustic tomography",
abstract = "Purpose: Optoacoustic tomography (OAT) is a novel medical imaging method that uses optical illumination and ultrasonic detection to produce deep tissue images based on their light absorption. Abnormal angiogenesis in advanced tumors, that increases the blood content of the tumor, is an endogenous contrast agent for OAT. In early stages, however, angiogenesis is not sufficient to differentiate a tumor from normal tissue; justifying the application of an exogenous contrast agent. We have developed a molecular based contrast agent composed of gold nanoparticles conjugated to a monoclonal antibody that improves OAT imaging to potentiate its use in imaging deep tumors in early stages of cancer or metastatic lesions. Procedure: Due to their strong optoacoustic signal, we used gold nanoparticles (NPs) as a contrast agent. To target NPs to breast cancer cells, we conjugated NPs to a monoclonal antibody that specifically binds cell surface receptors known to be overexpressed in human breast tumors. Results: In a series of in vitro experiments, Herceptin{\circledR} (monoclonal antibody that binds HER2/neu) conjugated to 40nm NPs (Mab/NPs) selectively targeted human SK-BR-3 breast cancer cells. The breast cancer cells were detected and imaged by OAT in a gelatin phantom that optically resembled breast tissue. Sensitivity experiments showed that a concentration as low as 10 9 NPs per ml were detectable at a depth of 6 cm. Conclusion: Experimental data together with theoretical analysis demonstrate the feasibility of detection of deeply seeded small tumors that express tumor associated antigens using targeted gold NPs and OAT.",
keywords = "Cancer, Detection, Diagnostics, Gold nanoparticles, Herceptin, Imaging, Laser optoacoustic imaging system, Molecular probes, Nanotechnology, Optoacoustics, Targeting",
author = "Copland, {John A.} and Mohammad Eghtedari and Vsevolod Popov and Nicholas Kotov and Natasha Mamedova and Massoud Motamedi and Oraevsky, {Alexander A.}",
year = "2004",
month = "9",
doi = "10.1016/j.mibio.2004.06.002",
language = "English (US)",
volume = "6",
pages = "341--349",
journal = "Molecular Imaging and Biology",
issn = "1536-1632",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Bioconjugated gold nanoparticles as a molecular based contrast agent

T2 - Implications for imaging of deep tumors using optoacoustic tomography

AU - Copland, John A.

AU - Eghtedari, Mohammad

AU - Popov, Vsevolod

AU - Kotov, Nicholas

AU - Mamedova, Natasha

AU - Motamedi, Massoud

AU - Oraevsky, Alexander A.

PY - 2004/9

Y1 - 2004/9

N2 - Purpose: Optoacoustic tomography (OAT) is a novel medical imaging method that uses optical illumination and ultrasonic detection to produce deep tissue images based on their light absorption. Abnormal angiogenesis in advanced tumors, that increases the blood content of the tumor, is an endogenous contrast agent for OAT. In early stages, however, angiogenesis is not sufficient to differentiate a tumor from normal tissue; justifying the application of an exogenous contrast agent. We have developed a molecular based contrast agent composed of gold nanoparticles conjugated to a monoclonal antibody that improves OAT imaging to potentiate its use in imaging deep tumors in early stages of cancer or metastatic lesions. Procedure: Due to their strong optoacoustic signal, we used gold nanoparticles (NPs) as a contrast agent. To target NPs to breast cancer cells, we conjugated NPs to a monoclonal antibody that specifically binds cell surface receptors known to be overexpressed in human breast tumors. Results: In a series of in vitro experiments, Herceptin® (monoclonal antibody that binds HER2/neu) conjugated to 40nm NPs (Mab/NPs) selectively targeted human SK-BR-3 breast cancer cells. The breast cancer cells were detected and imaged by OAT in a gelatin phantom that optically resembled breast tissue. Sensitivity experiments showed that a concentration as low as 10 9 NPs per ml were detectable at a depth of 6 cm. Conclusion: Experimental data together with theoretical analysis demonstrate the feasibility of detection of deeply seeded small tumors that express tumor associated antigens using targeted gold NPs and OAT.

AB - Purpose: Optoacoustic tomography (OAT) is a novel medical imaging method that uses optical illumination and ultrasonic detection to produce deep tissue images based on their light absorption. Abnormal angiogenesis in advanced tumors, that increases the blood content of the tumor, is an endogenous contrast agent for OAT. In early stages, however, angiogenesis is not sufficient to differentiate a tumor from normal tissue; justifying the application of an exogenous contrast agent. We have developed a molecular based contrast agent composed of gold nanoparticles conjugated to a monoclonal antibody that improves OAT imaging to potentiate its use in imaging deep tumors in early stages of cancer or metastatic lesions. Procedure: Due to their strong optoacoustic signal, we used gold nanoparticles (NPs) as a contrast agent. To target NPs to breast cancer cells, we conjugated NPs to a monoclonal antibody that specifically binds cell surface receptors known to be overexpressed in human breast tumors. Results: In a series of in vitro experiments, Herceptin® (monoclonal antibody that binds HER2/neu) conjugated to 40nm NPs (Mab/NPs) selectively targeted human SK-BR-3 breast cancer cells. The breast cancer cells were detected and imaged by OAT in a gelatin phantom that optically resembled breast tissue. Sensitivity experiments showed that a concentration as low as 10 9 NPs per ml were detectable at a depth of 6 cm. Conclusion: Experimental data together with theoretical analysis demonstrate the feasibility of detection of deeply seeded small tumors that express tumor associated antigens using targeted gold NPs and OAT.

KW - Cancer

KW - Detection

KW - Diagnostics

KW - Gold nanoparticles

KW - Herceptin

KW - Imaging

KW - Laser optoacoustic imaging system

KW - Molecular probes

KW - Nanotechnology

KW - Optoacoustics

KW - Targeting

UR - http://www.scopus.com/inward/record.url?scp=4544306615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544306615&partnerID=8YFLogxK

U2 - 10.1016/j.mibio.2004.06.002

DO - 10.1016/j.mibio.2004.06.002

M3 - Article

C2 - 15380744

AN - SCOPUS:4544306615

VL - 6

SP - 341

EP - 349

JO - Molecular Imaging and Biology

JF - Molecular Imaging and Biology

SN - 1536-1632

IS - 5

ER -